FOERFARANDE FOER FRAMSTAELLNING AV EN ANTIBIOTISKT VERKANDE 7-ETA-ACYLAMIDOCEF-3-EM-4-KARBOXYLSYRA

A procedure for the preparation of antibiotic cephalosporin compounds of the general formula: **(See formula)** (where R is thienyl or furyl; Ra and Rb, which may be the same or different, are each selected from hydrogen, C1-4 alcohol, C3-7 cycloalkyl alkenyl, phenyl, naphthyl, thienyl, furyl, carbo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: COOK MARTIN CHRISTOPHER, BRADSHAW JANICE, SUTHERLAND DEREK RONALD, COCKER JOHN DEREK, GREGORY GORDON IAN
Format: Patent
Sprache:fin
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator COOK MARTIN CHRISTOPHER
BRADSHAW JANICE
SUTHERLAND DEREK RONALD
COCKER JOHN DEREK
GREGORY GORDON IAN
description A procedure for the preparation of antibiotic cephalosporin compounds of the general formula: **(See formula)** (where R is thienyl or furyl; Ra and Rb, which may be the same or different, are each selected from hydrogen, C1-4 alcohol, C3-7 cycloalkyl alkenyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl and cyano; or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkoxynyl or cycloalkenylidene group; m and n are each 0 or 1 such that the sum of m and n is 0 or 1; and Y is the residue of a nucleophile or a derivative of the residue of a nucleophile or its non-toxic derivatives, said compounds being a isomer without or presenting as a mixture of the sin and anti isomers containing at least 90% of the sin isomer, characterized in that a compound of the formula is reacted **(See formula)** (Where B, R, Ra, Rb, m and n are as defined above each can independently represent hydrogen or a carboxyl blocking group; Y1 is a substitutable residue of a nucleophile; and the dotted line joining the 2 positions, 3 and 4 indicate that the compound is a cef-2-em or cef-3-em) compound with a nucleophile; after which, if necessary and/or if desired in each case, some of the following reactions are carried out in any appropriate sequence: i) conversion of an isomer (see formula) to the desired isomer (see formula), ii) reduction of a compound where B is (see formula) to form a compound where B is> S; iii) reduction of a 3-azidomethyl compound to form a 3-aminomethyl compound; iv) acylation of a 3-aminomethyl compound to form a 3-acylaminomethyl compound; v) reacting a 3-azidomethyl compound with a dipolarphile to form a compound having a polyazole ring attached to the 3-position carbon atom via a methylene group; vi) deacylation of a 3-acyloxymethyl compound to form a 3-hydroxymethyl compound; vii) acylation of a 3-bldroxymethyl compound to form a 3-acyloxymethyl compound, viii) carbamoylation of a 3-hydroxymethyl compound to form an unsubstituted or substituted 3-carbamoyloxymethyl compound, and ix) separation of groups of carboxyl block; and finally recover the desired compound of formula I or its non-toxic derivative, if necessary after separation of the isomers. (Machine-translation by Google Translate, not legally binding)
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FI65258BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FI65258BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FI65258BB3</originalsourceid><addsrcrecordid>eNqFyr0KwjAUQOEuDqK-guQF7mKtut6kNxryB0koZipV4iRaqO-PKO5O5wzfvLpIT0FiQNcS-zyTAW1MSMY45Y4MO0aOoUuKK59U1Il1FPTX74ESAops0KrWC5JQA1nYgsbA_TmbmAMuq9ltuE9l9euiWktK4gRlfPZlGodreZRXL9Wu2TQHzuu_4A2hbzKs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FOERFARANDE FOER FRAMSTAELLNING AV EN ANTIBIOTISKT VERKANDE 7-ETA-ACYLAMIDOCEF-3-EM-4-KARBOXYLSYRA</title><source>esp@cenet</source><creator>COOK MARTIN CHRISTOPHER ; BRADSHAW JANICE ; SUTHERLAND DEREK RONALD ; COCKER JOHN DEREK ; GREGORY GORDON IAN</creator><creatorcontrib>COOK MARTIN CHRISTOPHER ; BRADSHAW JANICE ; SUTHERLAND DEREK RONALD ; COCKER JOHN DEREK ; GREGORY GORDON IAN</creatorcontrib><description>A procedure for the preparation of antibiotic cephalosporin compounds of the general formula: **(See formula)** (where R is thienyl or furyl; Ra and Rb, which may be the same or different, are each selected from hydrogen, C1-4 alcohol, C3-7 cycloalkyl alkenyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl and cyano; or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkoxynyl or cycloalkenylidene group; m and n are each 0 or 1 such that the sum of m and n is 0 or 1; and Y is the residue of a nucleophile or a derivative of the residue of a nucleophile or its non-toxic derivatives, said compounds being a isomer without or presenting as a mixture of the sin and anti isomers containing at least 90% of the sin isomer, characterized in that a compound of the formula is reacted **(See formula)** (Where B, R, Ra, Rb, m and n are as defined above each can independently represent hydrogen or a carboxyl blocking group; Y1 is a substitutable residue of a nucleophile; and the dotted line joining the 2 positions, 3 and 4 indicate that the compound is a cef-2-em or cef-3-em) compound with a nucleophile; after which, if necessary and/or if desired in each case, some of the following reactions are carried out in any appropriate sequence: i) conversion of an isomer (see formula) to the desired isomer (see formula), ii) reduction of a compound where B is (see formula) to form a compound where B is&gt; S; iii) reduction of a 3-azidomethyl compound to form a 3-aminomethyl compound; iv) acylation of a 3-aminomethyl compound to form a 3-acylaminomethyl compound; v) reacting a 3-azidomethyl compound with a dipolarphile to form a compound having a polyazole ring attached to the 3-position carbon atom via a methylene group; vi) deacylation of a 3-acyloxymethyl compound to form a 3-hydroxymethyl compound; vii) acylation of a 3-bldroxymethyl compound to form a 3-acyloxymethyl compound, viii) carbamoylation of a 3-hydroxymethyl compound to form an unsubstituted or substituted 3-carbamoyloxymethyl compound, and ix) separation of groups of carboxyl block; and finally recover the desired compound of formula I or its non-toxic derivative, if necessary after separation of the isomers. (Machine-translation by Google Translate, not legally binding)</description><edition>3</edition><language>fin</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1983</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19831230&amp;DB=EPODOC&amp;CC=FI&amp;NR=65258B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19831230&amp;DB=EPODOC&amp;CC=FI&amp;NR=65258B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COOK MARTIN CHRISTOPHER</creatorcontrib><creatorcontrib>BRADSHAW JANICE</creatorcontrib><creatorcontrib>SUTHERLAND DEREK RONALD</creatorcontrib><creatorcontrib>COCKER JOHN DEREK</creatorcontrib><creatorcontrib>GREGORY GORDON IAN</creatorcontrib><title>FOERFARANDE FOER FRAMSTAELLNING AV EN ANTIBIOTISKT VERKANDE 7-ETA-ACYLAMIDOCEF-3-EM-4-KARBOXYLSYRA</title><description>A procedure for the preparation of antibiotic cephalosporin compounds of the general formula: **(See formula)** (where R is thienyl or furyl; Ra and Rb, which may be the same or different, are each selected from hydrogen, C1-4 alcohol, C3-7 cycloalkyl alkenyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl and cyano; or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkoxynyl or cycloalkenylidene group; m and n are each 0 or 1 such that the sum of m and n is 0 or 1; and Y is the residue of a nucleophile or a derivative of the residue of a nucleophile or its non-toxic derivatives, said compounds being a isomer without or presenting as a mixture of the sin and anti isomers containing at least 90% of the sin isomer, characterized in that a compound of the formula is reacted **(See formula)** (Where B, R, Ra, Rb, m and n are as defined above each can independently represent hydrogen or a carboxyl blocking group; Y1 is a substitutable residue of a nucleophile; and the dotted line joining the 2 positions, 3 and 4 indicate that the compound is a cef-2-em or cef-3-em) compound with a nucleophile; after which, if necessary and/or if desired in each case, some of the following reactions are carried out in any appropriate sequence: i) conversion of an isomer (see formula) to the desired isomer (see formula), ii) reduction of a compound where B is (see formula) to form a compound where B is&gt; S; iii) reduction of a 3-azidomethyl compound to form a 3-aminomethyl compound; iv) acylation of a 3-aminomethyl compound to form a 3-acylaminomethyl compound; v) reacting a 3-azidomethyl compound with a dipolarphile to form a compound having a polyazole ring attached to the 3-position carbon atom via a methylene group; vi) deacylation of a 3-acyloxymethyl compound to form a 3-hydroxymethyl compound; vii) acylation of a 3-bldroxymethyl compound to form a 3-acyloxymethyl compound, viii) carbamoylation of a 3-hydroxymethyl compound to form an unsubstituted or substituted 3-carbamoyloxymethyl compound, and ix) separation of groups of carboxyl block; and finally recover the desired compound of formula I or its non-toxic derivative, if necessary after separation of the isomers. (Machine-translation by Google Translate, not legally binding)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1983</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyr0KwjAUQOEuDqK-guQF7mKtut6kNxryB0koZipV4iRaqO-PKO5O5wzfvLpIT0FiQNcS-zyTAW1MSMY45Y4MO0aOoUuKK59U1Il1FPTX74ESAops0KrWC5JQA1nYgsbA_TmbmAMuq9ltuE9l9euiWktK4gRlfPZlGodreZRXL9Wu2TQHzuu_4A2hbzKs</recordid><startdate>19831230</startdate><enddate>19831230</enddate><creator>COOK MARTIN CHRISTOPHER</creator><creator>BRADSHAW JANICE</creator><creator>SUTHERLAND DEREK RONALD</creator><creator>COCKER JOHN DEREK</creator><creator>GREGORY GORDON IAN</creator><scope>EVB</scope></search><sort><creationdate>19831230</creationdate><title>FOERFARANDE FOER FRAMSTAELLNING AV EN ANTIBIOTISKT VERKANDE 7-ETA-ACYLAMIDOCEF-3-EM-4-KARBOXYLSYRA</title><author>COOK MARTIN CHRISTOPHER ; BRADSHAW JANICE ; SUTHERLAND DEREK RONALD ; COCKER JOHN DEREK ; GREGORY GORDON IAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FI65258BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fin</language><creationdate>1983</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>COOK MARTIN CHRISTOPHER</creatorcontrib><creatorcontrib>BRADSHAW JANICE</creatorcontrib><creatorcontrib>SUTHERLAND DEREK RONALD</creatorcontrib><creatorcontrib>COCKER JOHN DEREK</creatorcontrib><creatorcontrib>GREGORY GORDON IAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COOK MARTIN CHRISTOPHER</au><au>BRADSHAW JANICE</au><au>SUTHERLAND DEREK RONALD</au><au>COCKER JOHN DEREK</au><au>GREGORY GORDON IAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FOERFARANDE FOER FRAMSTAELLNING AV EN ANTIBIOTISKT VERKANDE 7-ETA-ACYLAMIDOCEF-3-EM-4-KARBOXYLSYRA</title><date>1983-12-30</date><risdate>1983</risdate><abstract>A procedure for the preparation of antibiotic cephalosporin compounds of the general formula: **(See formula)** (where R is thienyl or furyl; Ra and Rb, which may be the same or different, are each selected from hydrogen, C1-4 alcohol, C3-7 cycloalkyl alkenyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl and cyano; or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkoxynyl or cycloalkenylidene group; m and n are each 0 or 1 such that the sum of m and n is 0 or 1; and Y is the residue of a nucleophile or a derivative of the residue of a nucleophile or its non-toxic derivatives, said compounds being a isomer without or presenting as a mixture of the sin and anti isomers containing at least 90% of the sin isomer, characterized in that a compound of the formula is reacted **(See formula)** (Where B, R, Ra, Rb, m and n are as defined above each can independently represent hydrogen or a carboxyl blocking group; Y1 is a substitutable residue of a nucleophile; and the dotted line joining the 2 positions, 3 and 4 indicate that the compound is a cef-2-em or cef-3-em) compound with a nucleophile; after which, if necessary and/or if desired in each case, some of the following reactions are carried out in any appropriate sequence: i) conversion of an isomer (see formula) to the desired isomer (see formula), ii) reduction of a compound where B is (see formula) to form a compound where B is&gt; S; iii) reduction of a 3-azidomethyl compound to form a 3-aminomethyl compound; iv) acylation of a 3-aminomethyl compound to form a 3-acylaminomethyl compound; v) reacting a 3-azidomethyl compound with a dipolarphile to form a compound having a polyazole ring attached to the 3-position carbon atom via a methylene group; vi) deacylation of a 3-acyloxymethyl compound to form a 3-hydroxymethyl compound; vii) acylation of a 3-bldroxymethyl compound to form a 3-acyloxymethyl compound, viii) carbamoylation of a 3-hydroxymethyl compound to form an unsubstituted or substituted 3-carbamoyloxymethyl compound, and ix) separation of groups of carboxyl block; and finally recover the desired compound of formula I or its non-toxic derivative, if necessary after separation of the isomers. (Machine-translation by Google Translate, not legally binding)</abstract><edition>3</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language fin
recordid cdi_epo_espacenet_FI65258BB
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FOERFARANDE FOER FRAMSTAELLNING AV EN ANTIBIOTISKT VERKANDE 7-ETA-ACYLAMIDOCEF-3-EM-4-KARBOXYLSYRA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T00%3A36%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COOK%20MARTIN%20CHRISTOPHER&rft.date=1983-12-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFI65258BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true